COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Copeptin in Aortic Valve Replacement (CARE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01648647
Recruitment Status : Completed
First Posted : July 24, 2012
Last Update Posted : July 24, 2012
Information provided by (Responsible Party):
Deutsches Herzzentrum Muenchen

Brief Summary:
Copeptin is accepted as a marker of stress. We want to evaluate the preoperative and early postoperative copeptin leavens in patients undergoing different aortic valve procedures

Condition or disease
Copeptin in Patients Undergoing Aortic Valve Replacement

Layout table for study information
Study Type : Observational
Actual Enrollment : 50 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: GE DHM-AN-OR-2012/01
Study Start Date : May 2012

Resource links provided by the National Library of Medicine

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients scheduled for surgical or transcatheter aortic valve replacement

Inclusion Criteria:

  • Patients undergoing surgical aortic valve replacment
  • Patients undergoing transcatheter aortic valve replacment

Exclusion Criteria:

  • denial by patient

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01648647

Layout table for location information
Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München
Munich, Bavaria, Germany, D80636
Sponsors and Collaborators
Deutsches Herzzentrum Muenchen
Layout table for additonal information
Responsible Party: Deutsches Herzzentrum Muenchen Identifier: NCT01648647    
Other Study ID Numbers: GE DHM-AN-OR-2012/01
First Posted: July 24, 2012    Key Record Dates
Last Update Posted: July 24, 2012
Last Verified: July 2012
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes Insipidus
Kidney Diseases
Urologic Diseases
Pituitary Diseases
Endocrine System Diseases